本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：301126 证券简称：达嘉维康 公告编号：2025-053 一、担保情况概述 湖南达嘉维康医药产业股份有限公司（以下简称"公司"）为满足公司全资 子公司及控股子公司日常生产经营和业务发展资金需要，保证公司业务顺利开展， 公司于 2025 年 4 月 17 日、2025 年 5 月 12 日分别召开的第四届董事会第十四次会 议及 2024 年年度股东大会审议通过《关于 2025 年度担保额度预计的议案》，同意 公司 2025 年度为公司全资子公司及控股子公司提供担保，担保额度预计不超过 30 亿 元。具体内容详见公司于 2025 年 4 月 21 日在巨潮资讯网（http://www.cninfo.com.cn） 上披露的《关于 2025 年度担保额度预计的公告》（公告编号：2025-026）。 湖南达嘉维康医药产业股份有限公司 二、对外担保进展情况 关于对外担保的进展公告 近日，公司与交通银行股份有限公司湖南省分行（以下简称"交通银行"） 签订了《保证合同》，同意为全资子公司湖南达嘉维康医药有限公司（ ...

Core Insights - The pharmaceutical commercial sector experienced a slight increase of 0.05% on August 22, with Saily Medical leading the gains [1] - The Shanghai Composite Index closed at 3825.76, up 1.45%, while the Shenzhen Component Index closed at 12166.06, up 2.07% [1] Group 1: Stock Performance - Saily Medical (603716) saw a closing price of 31.52, with a significant increase of 10.02% and a trading volume of 614,300 shares, resulting in a transaction value of 1.861 billion yuan [1] - Guofang Co. (600538) closed at 6.55, up 2.18%, with a trading volume of 218,500 shares [1] - Runda Medical (603108) closed at 18.35, up 1.94%, with a trading volume of 303,900 shares [1] - Other notable stocks include Jiuzhoutong (600998) with a slight increase of 0.55% and Yifeng Pharmacy (603939) with a minimal increase of 0.20% [1] Group 2: Capital Flow - The pharmaceutical commercial sector saw a net inflow of 363 million yuan from main funds, while retail investors experienced a net outflow of 114 million yuan [2] - Speculative funds recorded a net outflow of 249 million yuan [2]

证券日报网讯达嘉维康（301126）8月19日在互动平台回答投资者提问时表示，截至2025年8月8日，公 司股东人数为19805户。 ...

从资金流向上来看，当日医药商业板块主力资金净流入4.72亿元，游资资金净流出2.9亿元，散户资金净 流出1.82亿元。医药商业板块个股资金流向见下表： 证券之星消息，8月19日医药商业板块较上一交易日上涨0.63%，塞力医疗领涨。当日上证指数报收于 3727.29，下跌0.02%。深证成指报收于11821.63，下跌0.12%。医药商业板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 603716 | 塞力医疗 | 31.40 | 5.12% | 61.67万 | | 19.77亿 | | 301408 | 华人健康 | 15.41 | 3.98% | 24.10万 | | 3.67亿 | | 301126 | 达嘉维康 | 13.24 | 3.36% | 19.13万 | | 2.54亿 | | 600538 | 国发股份 | 6.28 | 2.95% | 19.80万 | | 1.22亿 | | 603122 | 合富中国 | 7.25 | 2.55% | ...

Group 1 - The number of shareholders for Dajia Weikang as of August 10 is 19,805, a decrease of 1,648 from the previous period (July 31), representing a decline of 7.68% [2] - The latest stock price for Dajia Weikang is 12.87 yuan, an increase of 0.47%, with a cumulative increase of 2.80% since the concentration of chips [2] - The margin trading data shows that as of August 18, the total margin balance is 93.54 million yuan, with a financing balance of 93.54 million yuan, reflecting an increase of 26.63 million yuan, or 39.80%, since the concentration of chips [2] Group 2 - In the first quarter, Dajia Weikang achieved operating revenue of 1.3 billion yuan, a year-on-year increase of 1.51%, while net profit was 3.14 million yuan, a year-on-year decrease of 83.82% [2] - The basic earnings per share is 0.0200 yuan, and the weighted average return on net assets is 0.18% [2]

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 301408 | 华人健康 | 15.11 | -1.76% | 17.96万 | 2.71亿 | | 300937 | 药易购 | 30.05 | -1.60% | 4.53万 | 1.36亿 | | 301015 | 百洋医药 | 25.98 | -1.55% | 29.18万 | 7.77亿 | | 600272 | 开开实业 | 13.87 | -1.42% | 6.94万 | 9642.32万 | | 301126 | 达嘉维康 | 13.25 | -1.41% | 14.39万 | 1.91亿 | | 603122 | 合富中国 | 7.23 | -1.36% | 6.01万 | 4356.44万 | | 002589 | 瑞康医药 | 3.05 | -1.29% | 43.86万 | 1.34亿 | | 301017 | 款玉平民 | 13.20 | -0.98% | 4.94万 | 6532.05万 | | 605266 | 健之佳 ...

Core Viewpoint - Several shareholders across various companies are planning to reduce their stakes, with most reductions not exceeding 3% of total shares [1] Shareholder Reductions - Jiuliang Co., shareholders Rongxinliang and Zhuochu Guang plan to reduce their holdings by no more than 3% [1] - Inse Group, Orange Alliance Investment intends to reduce its stake by no more than 1% [1] - Xuelang Environment, shareholders Yang Jianping and Xu Huifen plan to reduce their holdings by a total of no more than 3% [1] - Haide Control, actual controller Guo Menglong plans to reduce his stake by no more than 3% [1] - Ailis, shareholders Shanghai Aixiang and Nantong Aiyun plan to reduce a total of no more than 13.5 million shares [1] - Huaxia Happiness, shareholders Ping An Life and Ping An Asset Management plan to reduce their holdings by a total of no more than 3% [1] - Tonglian Precision, actual controller Yang Hu plans to reduce his stake by no more than 2.375% [1] - Henggong Precision, shareholder Jingjinji Fund plans to reduce its stake by no more than 3% [1] - Dajia Weikang, director Zhong Xuesong plans to reduce his stake by no more than 1.7% [1] - Chuanwang Media, China Youth Publishing Group plans to reduce its stake by no more than 1% [1] Other Corporate Actions - Jinlihua Electric has terminated its plan for a major asset restructuring [1] - New Xiangwei has terminated the acquisition of 100% equity in Aixiangsheng [1]

Group 1 - The core viewpoint of the article highlights that Dajiahui Kang is focusing on the development of products and technologies in the field of regenerative medicine through collaborations with universities and hospitals [1] - The company aims to achieve scientific innovation and clinical transformation in regenerative medicine, thereby enhancing its production capabilities in this sector [1]

Group 1 - The article reports that 15 listed companies have disclosed share reduction plans, with no A-share increases on the same day [1] - Specific companies mentioned include Juguang Technology, Shiyun Circuit, Chuanwang Media, and others, indicating a trend of shareholder reductions [2] - The reductions range from 1% to over 3% of the companies' shares, with notable plans from major shareholders and executives [2]

Group 1 - The revenue composition of Dajia Weikang for the year 2024 is as follows: retail accounts for 51.44%, wholesale for 42.3%, industrial revenue for 5.73%, and services for 0.53% [1] Group 2 - Dajia Weikang announced that its board member, Mr. Zhong Xuesong, who holds approximately 19.29 million shares (9.39% of total shares), plans to reduce his holdings by up to 3.5 million shares (1.7% of total shares) through centralized bidding or block trading within three months starting from September 1, 2025 [3]